Do CASPR2 and GABA receptor antibodies alter synaptic signaling, while intracellular onconeural antibodies mark a paraneoplastic process?

The claim is supported: neuronal-surface and intracellular onconeural antibodies have importantly different pathogenic implications, although both can accompany serious cognitive, encephalitic, or paraneoplastic neurologic syndromes.

Surface-antibody clinical and mechanistic evidence

• CASPR2 antibodies disrupt CASPR2/contactin-2–associated Kv1 channel-domain organization, with impaired repolarization, reduced afterhyperpolarization, hippocampal afterpotentials, EEG hyperexcitability, and enhanced excitatory transmission. Altered AMPA-receptor trafficking may contribute.
• GABA(_A)-receptor antibodies reduce receptor clustering/synaptic density and can rapidly suppress inhibitory currents without reducing surface receptor abundance. GABA(_B)-receptor antibodies functionally antagonize receptor signaling: in cultured hippocampal neurons, they block baclofen-mediated suppression of firing without changing receptor abundance.
• These effects shift the excitatory–inhibitory balance toward disinhibition and hyperexcitability, providing a direct biological basis for seizures, including status epilepticus, and for limbic memory, behavioral, cognitive, and encephalopathic presentations. Clinical attribution of cognitive impairment remains less direct because seizures, sedatives, cancer, and acute illness can also impair cognition.

Intracellular onconeural antibodies and cancer-associated immunity

• Amphiphysin, CRMP5/CV2, and Yo antibodies target intracellular antigens, so their detection more strongly signals antigen-specific cellular antitumor immunity than antibody access to intact neurons.
• In anti-Yo paraneoplastic cerebellar degeneration, neuronal MHC-I upregulation plus perineuronal CD8-positive/granzyme-B-positive lymphocytes, with little or no complement deposition, supports cytotoxic T-cell-mediated neuronal killing. Passive-transfer studies have not consistently reproduced ataxia or Purkinje-cell loss.
• Amphiphysin may be a partial exception because transient membrane exposure could allow limited antibody effects, but this remains uncertain.

Bottom line

• Surface-directed CASPR2 and GABA-receptor antibodies can directly disturb synaptic physiology and plausibly drive encephalopathy and seizures; intracellular onconeural antibodies—especially Yo—primarily identify a T-cell-mediated paraneoplastic process, making timely tumor evaluation and control central to management.